A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

Clinical trial NCT06297590 · RECRUITING

Trial details

NCT number: NCT06297590
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2024-08-15
Primary completion: 2027-02-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.